Research Paper Volume 15, Issue 20 pp 11067—11091
HLA-DPA1 overexpression inhibits cancer progression, reduces resistance to cisplatin, and correlates with increased immune infiltration in lung adenocarcinoma
Figure 6. HLA-DPA1 overexpression inhibits cancer cell proliferation and promotes cell sensitivity to cisplatin in LUAD. (A–C) A549 and A549/DDP cell assays using RT-PCR and Western blotting (D, E) Assessment of A549 and A549/DDP cell proliferation; (F) A549/DDP cell sensitivity to cisplatin. Abbreviation: LUAD: lung adenocarcinoma.